These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 10945569)

  • 1. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa light chain myeloma with initial cutaneous involvement.
    Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
    Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
    Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
    Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cell leukaemia mimicking acute monocytic leukaemia in the course of multiple myeloma.
    Eclache V; Lusina D; Lejeune F; Casassus P; Smadja N; Lortholary P
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):419-22. PubMed ID: 8414961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
    Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell leukemia with pleomorphic plasma cells--a case report.
    John S; Feroze M; Supriya NK; Aisabi KA
    Indian J Pathol Microbiol; 2006 Jul; 49(3):438-9. PubMed ID: 17001915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
    Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
    Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A; Siracusano L; Armando S
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
    Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
    Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Bianchi G; Richardson PG; Anderson KC
    J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-Gaucher cells in multiple myeloma.
    Shenjere P; Roy A; Eyden B; Banerjee SS
    Int J Surg Pathol; 2008 Apr; 16(2):176-9. PubMed ID: 18417675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
    Méndez CE; Hwang BJ; Destian S; Mazumder A; Jagannath S; Vesole DH
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):220-3. PubMed ID: 20511169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia].
    Fujii H; Yashige H; Taniwaki M; Urata Y; Kuzuyama Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M
    Gan No Rinsho; 1990 Apr; 36(5):645-50. PubMed ID: 2109137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of multiple myeloma and related disorders including amyloidosis.
    Kyle RA
    Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma.
    Corso A; Arcaini L; Caberlon S; Zappasodi P; Mangiacavalli S; Lorenzi A; Rusconi C; Troletti D; Maiocchi MA; Pascutto C; Morra E; Lazzarino M
    Haematologica; 2002 Oct; 87(10):1041-5. PubMed ID: 12368158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
    Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
    Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgM myeloma: a report of 2 cases].
    Masanés F; Pedrol E; Bladé J; Casademont J; de la Sierra A; Martínez-Orozco F; Grau JM; Ingelmo M
    Med Clin (Barc); 1991 May; 96(20):777-9. PubMed ID: 1908542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.